Cue Biopharma Inc (CUE)
1.02
-0.01
(-0.97%)
USD |
NASDAQ |
Nov 22, 16:00
1.05
+0.03
(+2.94%)
After-Hours: 20:00
Cue Biopharma Shares Outstanding: 63.35M for Nov. 12, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 12, 2024 | 63.35M |
September 30, 2024 | 60.21M |
September 05, 2024 | 48.64M |
August 09, 2024 | 48.64M |
June 30, 2024 | 48.64M |
May 06, 2024 | 48.64M |
April 12, 2024 | 48.64M |
March 31, 2024 | 48.64M |
March 25, 2024 | 48.64M |
December 31, 2023 | 47.22M |
November 01, 2023 | 45.12M |
September 30, 2023 | 45.12M |
August 01, 2023 | 44.96M |
June 30, 2023 | 43.74M |
May 01, 2023 | 43.18M |
April 12, 2023 | 43.18M |
March 31, 2023 | 43.18M |
March 13, 2023 | 43.17M |
December 31, 2022 | 43.04M |
December 27, 2022 | 43.04M |
November 25, 2022 | 43.04M |
November 16, 2022 | 43.04M |
November 01, 2022 | 35.39M |
September 30, 2022 | 35.39M |
August 01, 2022 | 35.38M |
Date | Value |
---|---|
June 30, 2022 | 35.38M |
May 02, 2022 | 35.37M |
April 12, 2022 | 35.37M |
March 31, 2022 | 34.17M |
March 07, 2022 | 33.01M |
December 31, 2021 | 32.20M |
November 01, 2021 | 31.76M |
September 30, 2021 | 31.63M |
August 02, 2021 | 31.51M |
June 30, 2021 | 31.47M |
May 03, 2021 | 31.41M |
April 12, 2021 | 30.50M |
March 31, 2021 | 30.50M |
March 01, 2021 | 30.46M |
December 31, 2020 | 30.35M |
November 02, 2020 | 30.28M |
September 30, 2020 | 30.25M |
August 03, 2020 | 29.50M |
June 30, 2020 | 29.30M |
May 18, 2020 | 28.45M |
May 01, 2020 | 28.43M |
April 30, 2020 | 28.40M |
April 27, 2020 | 28.40M |
April 23, 2020 | 27.67M |
March 31, 2020 | 26.58M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
22.99M
Minimum
Dec 17 2019
63.35M
Maximum
Nov 12 2024
37.54M
Average
35.37M
Median
Apr 12 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Arbutus Biopharma Corp | 189.49M |
GlycoMimetics Inc | 64.48M |
FibroGen Inc | 100.77M |
Cidara Therapeutics Inc | 7.047M |